论文部分内容阅读
目的:观察复方斑蝥酸钠注射液联合NP方案治疗中晚期非小细胞肺癌的效果。方法:选取本院于2013年5月-2015年5月收治的86例中晚期非小细胞肺癌患者,将其随机分为观察组和对照组各43例,对照组采用NP方案治疗法,观察组采用复方斑蝥酸钠注射液联合NP方案治疗,对比两组患者的临床疗效和不良反应发生率。结果:观察组总有效率93.02%高于对照组的76.74%(P<0.05);观察组胃肠道反应以及白细胞减少的各个不同划分标准下的不良反应发生率都明显低于对照组,差异具有统计学意义(P<0.05)。结论:中晚期非小细胞肺癌患者采用复方斑蝥酸钠注射液联合NP方案开展治疗过程后,可以起到很好的抗癌、抑癌功效,进一步有助于体内白细胞增多,也可以明显降低不良反应发生率,促进患者病情稳定,及早康复。
Objective: To observe the effect of compound cantharidate sodium injection and NP regimen in the treatment of advanced non-small cell lung cancer. Methods: Totally 86 patients with advanced non-small cell lung cancer who were treated in our hospital from May 2013 to May 2015 were randomly divided into observation group (43 cases) and control group (43 cases). The control group was treated with NP regimen The patients were treated with sodium cantharidate injection combined with NP regimen, and the clinical efficacy and incidence of adverse reactions were compared between the two groups. Results: The total effective rate in the observation group was 93.02%, which was significantly higher than that in the control group (76.74%, P <0.05). The incidences of adverse reactions in the observation group were significantly lower than those in the control group in the different division criteria of gastrointestinal tract and leukopenia Statistically significant (P <0.05). Conclusion: The treatment of advanced non-small cell lung cancer patients with combined sodium cantharidate injection and NP regimen can play a good anti-cancer and anti-cancer effect, further help to increase the body’s leukocytosis, but also significantly reduce the adverse Reaction rate, promote stable patient condition, early recovery.